These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
170 related articles for article (PubMed ID: 29489433)
1. Brachytherapy-Based Radiotherapy and Radical Prostatectomy Are Associated With Similar Survival in High-Risk Localized Prostate Cancer. Ennis RD; Hu L; Ryemon SN; Lin J; Mazumdar M J Clin Oncol; 2018 Apr; 36(12):1192-1198. PubMed ID: 29489433 [TBL] [Abstract][Full Text] [Related]
2. Survival after radiotherapy vs. radical prostatectomy for unfavorable intermediate-risk prostate cancer. Sebastian NT; McElroy JP; Martin DD; Sundi D; Diaz DA Urol Oncol; 2019 Nov; 37(11):813.e11-813.e19. PubMed ID: 31109836 [TBL] [Abstract][Full Text] [Related]
3. Radical prostatectomy versus external beam radiation therapy for high-grade, clinically localized prostate cancer: Emulation of a target clinical trial. Reitblat C; Fleishman A; Kaplan IA; Stensland KD; D'Amico AV; Olumi AF; Wagner AA; Chang PK; Kim SP; Korets R; Gershman B Urol Oncol; 2021 Nov; 39(11):785.e1-785.e10. PubMed ID: 33934965 [TBL] [Abstract][Full Text] [Related]
4. Radical Prostatectomy, External Beam Radiotherapy, or External Beam Radiotherapy With Brachytherapy Boost and Disease Progression and Mortality in Patients With Gleason Score 9-10 Prostate Cancer. Kishan AU; Cook RR; Ciezki JP; Ross AE; Pomerantz MM; Nguyen PL; Shaikh T; Tran PT; Sandler KA; Stock RG; Merrick GS; Demanes DJ; Spratt DE; Abu-Isa EI; Wedde TB; Lilleby W; Krauss DJ; Shaw GK; Alam R; Reddy CA; Stephenson AJ; Klein EA; Song DY; Tosoian JJ; Hegde JV; Yoo SM; Fiano R; D'Amico AV; Nickols NG; Aronson WJ; Sadeghi A; Greco S; Deville C; McNutt T; DeWeese TL; Reiter RE; Said JW; Steinberg ML; Horwitz EM; Kupelian PA; King CR JAMA; 2018 Mar; 319(9):896-905. PubMed ID: 29509865 [TBL] [Abstract][Full Text] [Related]
5. Oncologic outcome of radical prostatectomy versus radiotherapy as primary treatment for high and very high risk localized prostate cancer. Emam A; Hermann G; Attwood K; Ji W; James G; Kuettel M; Mohler JL Prostate; 2021 Mar; 81(4):223-230. PubMed ID: 33471385 [TBL] [Abstract][Full Text] [Related]
6. Comparative effectiveness of surgery versus external beam radiation with/without brachytherapy in high-risk localized prostate cancer. Yin M; Zhao J; Monk P; Martin D; Folefac E; Joshi M; Jin N; Mortazavi A; Verschraegen C; Clinton S Cancer Med; 2020 Jan; 9(1):27-34. PubMed ID: 31697452 [TBL] [Abstract][Full Text] [Related]
7. Comparative Effectiveness of Radical Prostatectomy Versus External Beam Radiation Therapy Plus Brachytherapy in Patients with High-risk Localized Prostate Cancer. Berg S; Cole AP; Krimphove MJ; Nabi J; Marchese M; Lipsitz SR; Noldus J; Choueiri TK; Kibel AS; Trinh QD Eur Urol; 2019 Apr; 75(4):552-555. PubMed ID: 30420255 [TBL] [Abstract][Full Text] [Related]
8. Combined External Beam Radiation Therapy and Brachytherapy versus Radical Prostatectomy with Adjuvant Radiation Therapy for Gleason 9-10 Prostate Cancer. Muralidhar V; Mahal BA; Butler S; Lamba N; Yang DD; Leeman J; D'Amico AV; Nguyen PL; Trinh QD; Orio PF; King MT J Urol; 2019 Nov; 202(5):973-978. PubMed ID: 31144590 [TBL] [Abstract][Full Text] [Related]
9. External Beam Radiation Therapy With a Brachytherapy Boost Versus Radical Prostatectomy in Gleason Pattern 5 Prostate Cancer: A Population-Based Cohort Study. Wang C; Kishan AU; Kamrava M; Steinberg ML; King CR Int J Radiat Oncol Biol Phys; 2017 Aug; 98(5):1045-1052. PubMed ID: 28721887 [TBL] [Abstract][Full Text] [Related]
10. Clinical Outcomes for Patients with Gleason Score 9-10 Prostate Adenocarcinoma Treated With Radiotherapy or Radical Prostatectomy: A Multi-institutional Comparative Analysis. Kishan AU; Shaikh T; Wang PC; Reiter RE; Said J; Raghavan G; Nickols NG; Aronson WJ; Sadeghi A; Kamrava M; Demanes DJ; Steinberg ML; Horwitz EM; Kupelian PA; King CR Eur Urol; 2017 May; 71(5):766-773. PubMed ID: 27452951 [TBL] [Abstract][Full Text] [Related]
11. Are biochemical recurrence outcomes similar after radical prostatectomy and radiation therapy? Analysis of prostate cancer-specific mortality by nomogram-predicted risks of biochemical recurrence. Lee BH; Kibel AS; Ciezki JP; Klein EA; Reddy CA; Yu C; Kattan MW; Stephenson AJ Eur Urol; 2015 Feb; 67(2):204-9. PubMed ID: 25294696 [TBL] [Abstract][Full Text] [Related]
12. Ten-year survival after High-Dose-Rate Brachytherapy combined with External Beam Radiation Therapy in high-risk prostate cancer: A comparison with the Norwegian SPCG-7 cohort. Wedde TB; Småstuen MC; Brabrand S; Fosså SD; Kaasa S; Tafjord G; Russnes KM; Hellebust TP; Lilleby W Radiother Oncol; 2019 Mar; 132():211-217. PubMed ID: 30389241 [TBL] [Abstract][Full Text] [Related]
13. A prospective quality-of-life study in men with clinically localized prostate carcinoma treated with radical prostatectomy, external beam radiotherapy, or interstitial brachytherapy. Lee WR; Hall MC; McQuellon RP; Case LD; McCullough DL Int J Radiat Oncol Biol Phys; 2001 Nov; 51(3):614-23. PubMed ID: 11597800 [TBL] [Abstract][Full Text] [Related]
14. The Prognosis of Radical Prostatectomy, External Beam Radiotherapy plus Brachytherapy, and External Beam Radiotherapy Alone for Patients above 70 Years with Very High-Risk Prostate Cancer: A Population-Matched Study. Song P; Shu M; Yang L; Di X; Liu P; Liu Z; Zhou J; Dong Q Urol Int; 2022; 106(1):11-19. PubMed ID: 34515256 [TBL] [Abstract][Full Text] [Related]
15. Survival after Radical Prostatectomy versus Radiation Therapy in High-Risk and Very High-Risk Prostate Cancer. Chierigo F; Wenzel M; Würnschimmel C; Flammia RS; Horlemann B; Tian Z; Saad F; Chun FKH; Graefen M; Gallucci M; Shariat SF; Mantica G; Borghesi M; Suardi N; Terrone C; Karakiewicz PI J Urol; 2022 Feb; 207(2):375-384. PubMed ID: 34555930 [TBL] [Abstract][Full Text] [Related]
16. Survival outcomes of combined external beam radiotherapy and brachytherapy vs. brachytherapy alone for intermediate-risk prostate cancer patients using the National Cancer Data Base. Amini A; Jones BL; Jackson MW; Rusthoven CG; Maroni P; Kavanagh BD; Raben D Brachytherapy; 2016; 15(2):136-46. PubMed ID: 26825856 [TBL] [Abstract][Full Text] [Related]
17. Radical prostatectomy, external beam radiotherapy <72 Gy, external beam radiotherapy > or =72 Gy, permanent seed implantation, or combined seeds/external beam radiotherapy for stage T1-T2 prostate cancer. Kupelian PA; Potters L; Khuntia D; Ciezki JP; Reddy CA; Reuther AM; Carlson TP; Klein EA Int J Radiat Oncol Biol Phys; 2004 Jan; 58(1):25-33. PubMed ID: 14697417 [TBL] [Abstract][Full Text] [Related]
18. Mortality after prostate cancer treatment with radical prostatectomy, external-beam radiation therapy, or brachytherapy in men without comorbidity. Nepple KG; Stephenson AJ; Kallogjeri D; Michalski J; Grubb RL; Strope SA; Haslag-Minoff J; Piccirillo JF; Ciezki JP; Klein EA; Reddy CA; Yu C; Kattan MW; Kibel AS Eur Urol; 2013 Sep; 64(3):372-8. PubMed ID: 23506834 [TBL] [Abstract][Full Text] [Related]
19. Overall survival comparison between androgen deprivation therapy (ADT) plus external beam radiation therapy (EBRT) vs ADT plus EBRT with brachytherapy boost in clinically node-positive prostate cancer. Fischer-Valuck BW; Rao YJ; Brenneman RJ; Patel PR; Filson CP; Jani AB; Liu Y; Goyal S; Xu K; Weiss A; Kucuk O; Cimmino C; Szabo S; Rossi P; Baumann BC; Pattaras J; Hershatter B; Patel SA Brachytherapy; 2020; 19(5):557-566. PubMed ID: 32624405 [TBL] [Abstract][Full Text] [Related]
20. Propensity-weighted long-term risk of urinary adverse events after prostate cancer surgery, radiation, or both. Jarosek SL; Virnig BA; Chu H; Elliott SP Eur Urol; 2015 Feb; 67(2):273-80. PubMed ID: 25217421 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]